The need for restructuring the disordered science of amorphous drug formulations

K Edueng, D Mahlin, CAS Bergström - Pharmaceutical research, 2017 - Springer
The alarming numbers of poorly soluble discovery compounds have centered the efforts
towards finding strategies to improve the solubility. One of the attractive approaches to …

Obtaining cocrystals by reaction crystallization method: Pharmaceutical applications

IFB Biscaia, SN Gomes, LS Bernardi, PR Oliveira - Pharmaceutics, 2021 - mdpi.com
Cocrystals have gained attention in the pharmaceutical industry due to their ability to
improve solubility, stability, in vitro dissolution rate, and bioavailability of poorly soluble …

Application of multivariate adaptive regression splines (MARSplines) Methodology for screening of dicarboxylic acid cocrystal using 1D and 2D molecular descriptors

M Przybyłek, T Jeliński, J Słabuszewska… - Crystal Growth & …, 2019 - ACS Publications
Dicarboxylic acids (DiAs) are probably among of the most popular cocrystal formers. Due to
the high hydrophilicity and nontoxicity, they are promising solubilizers of active …

Modulating the dissolution and mechanical properties of resveratrol by cocrystallization

H He, Q Zhang, M Li, JR Wang, X Mei - Crystal Growth & Design, 2017 - ACS Publications
Resveratrol (RSV), a dietary polyphenol found in red wine, has renewed interest in recent
years due to a broad range of in vitro evidence that indicate cardioprotective effects. Herein …

New Salt and Cocrystal of Mequitazine: Impact of Coformer Flexibility and Hydrogen Bond Donors on Polymorphism

R Okura, H Uchiyama, K Kadota… - Crystal Growth & …, 2020 - ACS Publications
New multicomponent crystals of mequitazine (MQZ) with succinic acid (SUC), fumaric acid
(FUM), glycolic acid (GLC), and glycolamide (GLA) were obtained after liquid-assisted …

Synthesis of a series of Pd (ii) complexes of the type [Pd (1, 10-phen)(SR F) 2]: an interesting case of solvatomorphism

H Juarez-Garrido, JM Germán-Acacio, E Jaime-Adán… - …, 2022 - pubs.rsc.org
In this work, the formation of non-solvated crystalline structure [Pd (1, 10-phen)(2, 3, 5, 6-S-
C6F4H) 2] 1 (1, 10-phen= 1, 10-phenanthroline) and three different crystalline …

Solvatomorphism in (Z)-4-fluoro-N′-(3-fluorophenyl) benzimidamide: the role of intermolecular O–H⋯ F interaction

D Dey, D Chopra - CrystEngComm, 2016 - pubs.rsc.org
The synthesized compound (Z)-4-fluoro-N′-(3-fluorophenyl) benzimidamide exhibits
solvatomorphism in the solid state. The anhydrous and the hydrate forms were obtained at …

Cocrystal

K Iwata, Y Ikeda - US Patent 10,906,898, 2021 - Google Patents
Improving the solubility of an organic compound. A coc rystal of (1) 6-ethyl-N-[1-
(hydroxyacetyl) piperidin-4-yl]-1 methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2, 2, 2-trifluoro …

[HTML][HTML] Molecular Mechanisms Influencing the Performance of Amorphous Formulations for Poorly Water-Soluble Drugs

K Edueng - 2019 - diva-portal.org
In the first part of the thesis, a systematic protocol was proposed to identify mechanisms via
which crystallisation takes place when amorphous drug is dissolved. The stabilisation …

Cocrystal

K Iwata, Y Ikeda - US Patent 12,024,512, 2024 - Google Patents
Improving the solubility of an organic compound. A cocrystal of (1) 6-ethyl-N-[1-
(hydroxyacetyl) piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2, 2, 2 …